Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment: An Observational Cohort Study with Independent Validation, Am J Respir Crit Care Med, 2018. ,
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial, Lancet, vol.387, pp.2630-2640, 2016. ,
Benign mediastinal lymphadenopathy in congestive heart failure, Chest, vol.119, issue.2, pp.653-659, 2001. ,
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature, Autoimmun Rev, vol.13, issue.2, pp.151-157, 2014. ,
Exposure to Ambient Particulate Matter Is Associated With Accelerated Functional Decline in Idiopathic Pulmonary Fibrosis, Chest, vol.153, issue.5, pp.1221-1228, 2018. ,
The presence of autoimmune antibodies in pulmonary alveolar proteinosis does not necessarily imply idiopathic disease, Lancet Respir Med, vol.6, issue.9, p.48, 2018. ,